Abstract
Background There are many barriers that hinder breast cancer (BC) early detection such as social, demographic, and economic factors. We examined the barriers to early detection.
Methods PubMed, Scopus, and Web of Science databases were chosen to conduct a comprehensive literature search. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) was used to select the relevant studies on decreased rate of BC screening, delayed presentation of BC, and advanced stage diagnosis of BC.
Results The literature demonstrates that several determinants had a significant impact on the delay in seeking medical help, rate of performing breast cancer screening (BCS), and stage at diagnosis of BC. Younger age, rural residence, being non-white, being single, low socioeconomic status, absence of medical insurance, having no paid job, low educational level, positive family history of BC, and having TNBC or HER2E BC subtypes were significantly associated with presenting at advanced stages, decreased rate of BCS, and delayed presentation. Meanwhile, the associations between BC and BMI, parity, religion, and menopausal status were underexamined in the literature.
Conclusion Promoting early detection of BC should be taking the sociodemographic disparities into consideration. To address these disparities, raising public awareness, implementing universal health coverage (UHC), and increasing government expenditure on health and education are needed, especially among vulnerable societies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- BC
- breast cancer
- HER2E
- HER2 enriched
- TNBC
- triple-negative breast cancer
- BMI
- body mass index
- BCS
- breast cancer screening
- UHC
- universal healthcare coverage